| Name | Title | Contact Details |
|---|
Recuro is a leading virtual-first care delivery company offering a personalized, holistic, and proactive approach to healthcare, looking to make advanced healthcare more accessible. Recuro provides seamless access to various virtual care services, including primary and urgent care, behavioral health, at-home lab testing, and genomics testing. Additionally, Recuro provides a comprehensive suite of supplemental benefits, integrated prescriptions, care management, and care navigation, all available on a unified platform.
Better Health Group is a national primary care platform that enables providers to shift focus to value-based care. They take a proactive approach by focusing on preventing disease rather than just treating symptoms.
Healthmap Solutions (Healthmap) is a NCQA-accredited industry leading kidney population health management company. Healthmap uses big data resources, integrated advanced technology, clinical expertise, and complex care management to improve the lives of people living with kidney disease. Healthmap also helps healthcare providers and payers achieve the value-based results they need. Our company is a diverse and growing organization committed to our clients, the patients we support, and our employees. We are champions for better health, for those who need us most.
Memorial Hospital is a proud part of University of Colorado Health, recognized as a national leader in quality and research. At the local level, Memorial provides a comprehensive list of inpatient and outpatient services at two hospitals and multiple outpatient locations. Memorial provides state-of-the-art, compassionate care in fields such as cardiology, neurology and oncology.
NYMOZARFEX (TM) is given in an in-office procedure that is administered in a few minutes without need of anesthesia or analgesia. The drug has been tested in clinical trials involving overall more than 1750 patients with over 1600 injections administered including over 1200 Fexapotide administrations. Fexapotide has led to significant long-term improvements and has shown an excellent safety profile without the side effects normally associated with existing BPH treatments.